Needham analyst Michael Matson reiterated a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00.Stay Ahead ...

NeoGenomics (NASDAQ:NEO) shares popped ~4% premarket on Wednesday after the oncology testing services company set a revenue ...

One Power, an industrial power company, announced it has appointed Eileen Fargis as its chief financial officer. Ms. Fargis’ brings leadership and financial knowledge as well as company expertise from ...

NeoGenomics, Inc. ("NeoGenomics" or the "Company") , a leading oncology testing services company, today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan. "We ...

NEO:BTQ) BTQ Technologies Acquires Cutting-Edge Computing-in-Memory Intellectual Property from Cimtech Technology Co.

The company said, “The Long-Range Plan builds upon the successful execution of the previous three years. NeoGenomics (NEO) intends to achieve ...

NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

As Asia continues to lead the charge in digital innovation the region has become a hotbed for the development and adoption of ...

The financial sector in the United States is undergoing a significant transformation, driven by the emergence of neobanks and ...